Combined Effects of Withania Somnifera & Syzgium Cumini on Hyperlipidemia

Withania somnifera and Syzygium cumini are known for their potential therapeutic effects, particularly in managing lipid disorders. This study was aimed to provide valuable insights into their separate and synergistic effect of Withania somnifera (Ashwagandha) and Syzygium cumini (Jamun) on hyperlipidemic patients. The study included 60 patients, equally divided into four groups. Pre- and post-treatment assessments were conducted over 3 months. Each group recieved different treatment. Data was analyzed using SPSS version 21 through paired sample t-test. The findings of the research showed that Withania somnifera showed significant improvement in improving lipid profile and associated factors and concluded that the combination may be an effective and safe approach for managing hyperlipidaemia due to its beneficial impact on lipid profile.

NCT Number	NCT07578857
Lead Sponsor	Riphah International University
Conditions	Hyperlipidemias
Enrollment	60 participants
Start Date	2023-05-24
Primary Completion	2023-10-10 (estimated)
Study Completion	2023-10-25 (estimated)
Updated on ClinicalTrials.gov	2026-06-10